NMTC NEUROONE MEDICAL TECHNOLOGIES Corp: institutional ownership and insider trading
24 funds reported holding $6.07M of NEUROONE MEDICAL TECHNOLOGIES Corp in their latest 13F filings; in Q2 2026 funds net bought $6.20M, with 23 new positions and 0 funds selling out; over the last 12 months insiders bought $737K and sold $54.9K on the open market.
Famous investors holding NMTC
- Renaissance Technologies (Renaissance Technologies): $215K, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $45.7K, 0.0% of the portfolio
Largest institutional holders of NMTC
- Bleichroeder LP — $2.03M
- VANGUARD CAPITAL MANAGEMENT LLC — $1.07M
- BARD ASSOCIATES INC — $929K
- PERKINS CAPITAL MANAGEMENT INC — $744K
- GEODE CAPITAL MANAGEMENT, LLC — $284K
- Sio Capital Management, LLC — $252K
- RENAISSANCE TECHNOLOGIES LLC — $215K
- VANGUARD FIDUCIARY TRUST CO — $149K
- Cambridge Investment Research Advisors, Inc. — $87.0K
- BlackRock, Inc. (BLK) — $76.4K
Recent NMTC insider trades
- Aug 27, 2026: Wambeke David J. bought 33,333 shares ($67.0K)
- Jun 30, 2026: Christianson Mark sold 10,000 shares ($31.8K)
- Mar 30, 2026: Christianson Mark sold 15,363 shares ($11.4K)
- Mar 13, 2026: Christianson Mark sold 917 shares ($734)
5%+ owners
- Brian Pratt: 12.5% (Schedule 13G/A, filed Jul 14, 2026)